| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,795 |
21,793 |
$1.40M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17,097 |
15,530 |
$527K |
| 90832 |
Psychotherapy, 30 minutes with patient |
16,186 |
13,348 |
$381K |
| L0650 |
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf |
181 |
128 |
$80K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,546 |
1,439 |
$64K |
| 99205 |
Prolong outpt/office vis |
429 |
369 |
$43K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,205 |
766 |
$9K |
| 92546 |
|
190 |
116 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
87 |
82 |
$7K |
| 92540 |
|
160 |
145 |
$6K |
| 20610 |
|
258 |
186 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
503 |
249 |
$5K |
| 95923 |
|
102 |
95 |
$3K |
| 93922 |
|
105 |
99 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
427 |
371 |
$3K |
| 95921 |
|
89 |
84 |
$2K |
| 96130 |
|
63 |
51 |
$1K |
| 99408 |
|
24 |
17 |
$567.41 |
| 92547 |
|
159 |
145 |
$416.76 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
44 |
43 |
$403.76 |
| 93000 |
|
34 |
32 |
$286.69 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
45 |
43 |
$251.29 |
| 86803 |
|
14 |
14 |
$186.74 |
| 86703 |
|
17 |
16 |
$164.40 |
| A4550 |
Surgical trays |
84 |
65 |
$127.22 |
| 36415 |
Collection of venous blood by venipuncture |
76 |
76 |
$110.31 |
| L0120 |
Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar) |
12 |
12 |
$83.55 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
17 |
$73.62 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
271 |
148 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
102 |
98 |
$0.00 |
| 97016 |
|
390 |
192 |
$0.00 |
| 1036F |
|
92 |
90 |
$0.00 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
18 |
13 |
$0.00 |
| E0730 |
Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation |
14 |
13 |
$0.00 |
| G3002 |
Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) |
849 |
816 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
159 |
149 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
94 |
89 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
99 |
94 |
$0.00 |
| 4004F |
|
132 |
126 |
$0.00 |
| 99490 |
Ccm add 20min |
103 |
101 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
91 |
88 |
$0.00 |
| 3046F |
|
220 |
211 |
$0.00 |